Fore Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fore Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.15 Million - $1.36 Million	-2,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $709,200 - $837,810	-1,500 Reduced 42.86%	2,000 $1.12 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $223,365 - $274,100	500 Added 16.67%	3,500 $1.66 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $1.43 Million - $1.82 Million	3,000 New	3,000 $1.45 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Fore Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fore Capital, LLC with notifications on news.